Zyflamend inhibits 78 percent of prostate cancer cells

by Medindia Content Team on  November 26, 2005 at 7:01 PM Cancer News
RSS Email Print This Page Comment
Font : A-A+

Zyflamend inhibits 78 percent of prostate cancer cells
An article published in the October issue of the journal Nutrition and Cancer says that Zyflamend, an herbal extract from olive oil could end the search for a drug to beat prostate cancer.

It was found that this element caused the prostate cancer cells to commit "suicide." The researchers report that the drug had the ability to inhibit 78 percent of the cancer cell growth plus it also caused "apoptosis". This is the natural process by which a cell dies. Cell death in this way is a physiological process and Zyflamend's ability to trigger this action bodes well for the future, according to the lead researcher in the study, Dr. Debra L. Bemis of Columbia University College of Physicians and Surgeons, New York. "Together, these results suggest that Zyflamend might have some chemopreventive utility against prostate cancer in men," she said.

It was also found that Zyflamend had both COX-1 and COX-2 inhibitory effects on the cancer cells and was shown to decrease the activity of both these enzymes in a dramatic manner in the laboratory setting. "We are currently conducting a Phase I clinical trial for men with a pre-cancerous lesion of the prostate -- prostatic intraepithelial neoplasia -- to gain some information as to Zyflamend's potential to prevent or slow... progression to prostate cancer," Dr. Bemis concluded.

The COX inhibitors are known to have some effect on prostate cancer cells, but are contraindicated in heart disease since they have adverse impact on the heart. Zyflamend was seen to have the similar chemical structure as that of Aspirin.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions
guest Sunday, November 27, 2005

The contraindications are heart disease only apply to the traditional Cox inhibitors, not Zyflamend. I received radiation treatment for prostate cancer in 2000, have used Zyflamend for about 3 years, and remain cancer free.

guest Sunday, November 27, 2005

I am a 70 year old with PIN. No cancer. I have been following these reports about Zyflamend since August. My urologist was not aware of the finding but he recommended that I hold off until furthur test are made. I have my next biopsy in March. Do you think it is wise to hold off from taking Zyflamend or are the side effects with the heart a serious problem. I have no heart problems or any other medical problems. I take one baby aspirin daily. Thank you.

More News on:

Prostate Cancer Cancer and Homeopathy Parkinsons Disease Surgical Treatment Trans-Urethral Resection of the Prostate Prostate Cancer Facts Cancer Facts Cancer Hematuria Prostate Cancer: Treatment Options Prostate Specific Antigen [PSA] 

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store


News Category

News Archive